International directory of genetic services.
Explore the source record for details and available documents.
Directories as Topic↗
Biomedical subjects
E Sharp
Publications and source records attributed to E Sharp.
Studies on the pathogenesis of parainfluenza type 3 virus infection in hamsters.
Explore the source record for details and available documents.
Animals↗
Special "Ars Medica" exhibition being brought to Detroit as feature for MSMS 1968 annual session.
Explore the source record for details and available documents.
Exhibitions as Topic↗
The pathogenesis of Theiler's GD VII encephalomyelitis virus infection in mice as studied by immunofluorescent technique and infectivity titrations.
Explore the source record for details and available documents.
Animals↗
A quadricuspid pulmonic valve diagnosed in a live newborn by two-dimensional echocardiography.
Quadricuspid pulmonic valve is a rare congenital anomaly which appears to occur in the absence of other cardiac or systemic anomalies. It predominates in males and tends to be clinically quiescent. The first case of quadricuspid pulmonic valve in a live newborn infant diagnosed by two-dimensional echocardiography is presented here with a review of the literature.
Female↗
School nursing: expelled for not trying.
Explore the source record for details and available documents.
Child↗
Recent advances in the management of biotherapy-related side effects: fatigue.
Limited information about fatigue patterns in patients with cancer exists in the biotherapy literature. When fatigue is mentioned, it is usually to state whether or not it was a dose-limiting side effect. No further data are provided on how fatigue was measured; which patterns were noted and when; and which relationships were found between fatigue and demographic characteristics, type of biologic response modifier, route of administration, or cumulative dose. Thus, there is little available in the biotherapy literature to guide nursing practice in managing this side effect. Theory that guides practice, however, often emanates from the personal experiences of the patients and from the clinical observations and intuitive hunches of the nurses and physicians participating in clinical trials. These individuals have been most generous in sharing their insights and unpublished data with the authors. This paper presents a comprehensive view of current knowledge on fatigue to guide present nursing practice with patients receiving biotherapy and to provide direction for future nursing and clinical trial research.
Fatigue↗
Cancer biotherapy with interferon, interleukin-2 and tumor-derived activated cells (TDAC).
Interleukin-2 (Il-2) allows for the therapeutic augmentation of immunity in vivo and/or in vitro. In extensive studies in nearly 1000 patients with advanced cancer, we have demonstrated that Il-2 by continuous infusion, with cellular therapy (LAK or TDAC), is feasible, cost effective and useful in selected patients with melanoma and kidney cancer. Studies in patients with other tumor types are underway.
Cells, Cultured↗